![Jonathan Synett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan Synett
Chief Investment Officer bij NCL Technology Ventures Ltd.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Jerry Biggs | M | - |
NCL Technology Ventures Ltd.
![]() NCL Technology Ventures Ltd. Investment ManagersFinance NCL Technology Ventures Ltd. (NCL Technology Ventures) is an venture capital firm founded in 2010 by Jerry Biggs. The firm is headquartered in London, United Kingdom. | 14 jaar |
Alan Robert Archer | M | 76 |
Alert Technology Ltd.
![]() Alert Technology Ltd. Electronic Equipment/InstrumentsElectronic Technology Alert Technology Ltd. engages in the manufacture of electronic measuring and esting equipment. The company was founded on August 29, 2005 and is headquartered in Devon, the United Kingdom. | - |
Nader Alaghband | M | 43 |
Ampersand Health Ltd.
![]() Ampersand Health Ltd. Packaged SoftwareTechnology Services Ampersand Health Ltd. engages in the development of digital therapeutics for inflammatory conditions. It offers My IBD Care and My Arthritis. The company was founded by Nader Alaghband, Gareth Cecil Parkes and Bu' Hayee on September 24, 2018 and is headquartered in London, the United Kingdom. | 6 jaar |
Nick Staples | M | - |
Avvinity Therapeutics Ltd.
![]() Avvinity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples. | - |
Simon Holden | M | - |
Viramal Ltd.
![]() Viramal Ltd. BiotechnologyHealth Technology Viramal Ltd. operates as a biotechnology company and develops drugs for male and female sexual and hormone problems. The company was founded by Oliver Bates and Finn Larsen in 2013 and is headquartered in London, the United Kingdom. | - |
Jonathan Moore | M | 57 |
Avvinity Therapeutics Ltd.
![]() Avvinity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples. | 8 jaar |
Mike Westby | M | - |
Avvinity Therapeutics Ltd.
![]() Avvinity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples. | 8 jaar |
Walter James Courage | M | 84 |
Viramal Ltd.
![]() Viramal Ltd. BiotechnologyHealth Technology Viramal Ltd. operates as a biotechnology company and develops drugs for male and female sexual and hormone problems. The company was founded by Oliver Bates and Finn Larsen in 2013 and is headquartered in London, the United Kingdom. | 11 jaar |
Finn Larsen | M | - |
Viramal Ltd.
![]() Viramal Ltd. BiotechnologyHealth Technology Viramal Ltd. operates as a biotechnology company and develops drugs for male and female sexual and hormone problems. The company was founded by Oliver Bates and Finn Larsen in 2013 and is headquartered in London, the United Kingdom. | 12 jaar |
Oliver Bates | M | - |
Viramal Ltd.
![]() Viramal Ltd. BiotechnologyHealth Technology Viramal Ltd. operates as a biotechnology company and develops drugs for male and female sexual and hormone problems. The company was founded by Oliver Bates and Finn Larsen in 2013 and is headquartered in London, the United Kingdom. | 11 jaar |
Marian U. Pardo | F | 78 |
Viramal Ltd.
![]() Viramal Ltd. BiotechnologyHealth Technology Viramal Ltd. operates as a biotechnology company and develops drugs for male and female sexual and hormone problems. The company was founded by Oliver Bates and Finn Larsen in 2013 and is headquartered in London, the United Kingdom. | - |
Loretta Margaret King | F | 49 |
Alert Technology Ltd.
![]() Alert Technology Ltd. Electronic Equipment/InstrumentsElectronic Technology Alert Technology Ltd. engages in the manufacture of electronic measuring and esting equipment. The company was founded on August 29, 2005 and is headquartered in Devon, the United Kingdom. | - |
Reid Hayden Archer | M | 43 |
Alert Technology Ltd.
![]() Alert Technology Ltd. Electronic Equipment/InstrumentsElectronic Technology Alert Technology Ltd. engages in the manufacture of electronic measuring and esting equipment. The company was founded on August 29, 2005 and is headquartered in Devon, the United Kingdom. | - |
Nick Thornilley | M | - |
Viramal Ltd.
![]() Viramal Ltd. BiotechnologyHealth Technology Viramal Ltd. operates as a biotechnology company and develops drugs for male and female sexual and hormone problems. The company was founded by Oliver Bates and Finn Larsen in 2013 and is headquartered in London, the United Kingdom. | - |
Vincent Patrick Kelly | M | - |
Azadyne Ltd.
![]() Azadyne Ltd. Pharmaceuticals: MajorHealth Technology Azadyne Ltd. is an Irish preclinical biotech company that has identified a new target within the body and a previously undrugged pathway to treat autoimmune diseases. Azadyne is based in Dublin2, IE. The company is able to selectively control natural regulatory pathways to modify specific pathogenic immune populations. The company's groundbreaking work in RNA modification has been supported by investment syndicates led by NCL. The company was founded in 2019 by Jason Rutt, Vincent Kelly, Stephen Connon, and Mike Southern to commercialize the pioneering work on the QTRT or TGT pathway carried out in Profs Kelly, Connon & Southerns labs at Trinity College Dublin. | 6 jaar |
Stephen Joseph Cannon | M | - |
Azadyne Ltd.
![]() Azadyne Ltd. Pharmaceuticals: MajorHealth Technology Azadyne Ltd. is an Irish preclinical biotech company that has identified a new target within the body and a previously undrugged pathway to treat autoimmune diseases. Azadyne is based in Dublin2, IE. The company is able to selectively control natural regulatory pathways to modify specific pathogenic immune populations. The company's groundbreaking work in RNA modification has been supported by investment syndicates led by NCL. The company was founded in 2019 by Jason Rutt, Vincent Kelly, Stephen Connon, and Mike Southern to commercialize the pioneering work on the QTRT or TGT pathway carried out in Profs Kelly, Connon & Southerns labs at Trinity College Dublin. | 6 jaar |
John Michael Southern | M | - |
Azadyne Ltd.
![]() Azadyne Ltd. Pharmaceuticals: MajorHealth Technology Azadyne Ltd. is an Irish preclinical biotech company that has identified a new target within the body and a previously undrugged pathway to treat autoimmune diseases. Azadyne is based in Dublin2, IE. The company is able to selectively control natural regulatory pathways to modify specific pathogenic immune populations. The company's groundbreaking work in RNA modification has been supported by investment syndicates led by NCL. The company was founded in 2019 by Jason Rutt, Vincent Kelly, Stephen Connon, and Mike Southern to commercialize the pioneering work on the QTRT or TGT pathway carried out in Profs Kelly, Connon & Southerns labs at Trinity College Dublin. | 6 jaar |
Clare Elizabeth Terlouw | F | 51 |
Avvinity Therapeutics Ltd.
![]() Avvinity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples. | - |
Nick Higgins | M | 67 |
Avvinity Therapeutics Ltd.
![]() Avvinity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples. | - |
Ben Cons | M | - |
Azadyne Ltd.
![]() Azadyne Ltd. Pharmaceuticals: MajorHealth Technology Azadyne Ltd. is an Irish preclinical biotech company that has identified a new target within the body and a previously undrugged pathway to treat autoimmune diseases. Azadyne is based in Dublin2, IE. The company is able to selectively control natural regulatory pathways to modify specific pathogenic immune populations. The company's groundbreaking work in RNA modification has been supported by investment syndicates led by NCL. The company was founded in 2019 by Jason Rutt, Vincent Kelly, Stephen Connon, and Mike Southern to commercialize the pioneering work on the QTRT or TGT pathway carried out in Profs Kelly, Connon & Southerns labs at Trinity College Dublin. | 2 jaar |
Patrick George O'Neill | M | - |
NCL Technology Ventures Ltd.
![]() NCL Technology Ventures Ltd. Investment ManagersFinance NCL Technology Ventures Ltd. (NCL Technology Ventures) is an venture capital firm founded in 2010 by Jerry Biggs. The firm is headquartered in London, United Kingdom. | 6 jaar |
Francis Chen | M | 75 |
NCL Technology Ventures Ltd.
![]() NCL Technology Ventures Ltd. Investment ManagersFinance NCL Technology Ventures Ltd. (NCL Technology Ventures) is an venture capital firm founded in 2010 by Jerry Biggs. The firm is headquartered in London, United Kingdom. | - |
Chris Lowe | M | - |
Avvinity Therapeutics Ltd.
![]() Avvinity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Antony Marcou | M | - |
Sports Revolution Ltd.
![]() Sports Revolution Ltd. Advertising/Marketing ServicesCommercial Services Sports Revolution Ltd. provides stadium advertising services. It offers sponsorship, consultancy, sport media planning and digital services. The company was founded in 2001 and is headquartered in London, the United Kingdom. | 12 jaar |
John Bainbridge | M | - |
The University of Manchester
| 5 jaar |
Pavlos Karydas | M | 49 |
The University of Manchester
| 5 jaar |
Graham Hutchins | M | - |
NCL Technology Ventures Ltd.
![]() NCL Technology Ventures Ltd. Investment ManagersFinance NCL Technology Ventures Ltd. (NCL Technology Ventures) is an venture capital firm founded in 2010 by Jerry Biggs. The firm is headquartered in London, United Kingdom. | - |
Pascal Jean-Noël Noth | M | - |
INSEAD
| 1 jaar |
Samantha Moss | F | 43 |
The University of Manchester
| 4 jaar |
Barrie Heptonstall | M | - |
The University of Manchester
| 3 jaar |
Josie Richardson | F | - |
The University of Manchester
| 3 jaar |
Kai Neng Heng | M | 45 |
The University of Manchester
| 4 jaar |
Lily Lin | F | 46 |
INSEAD
| 2 jaar |
Nishant Batra | M | 46 |
INSEAD
| 2 jaar |
George Joseph Audi | M | - |
INSEAD
| 2 jaar |
Anna Ushakova | F | 47 |
The University of Manchester
| 3 jaar |
Tamara Milovanovic | F | 43 |
INSEAD
| 1 jaar |
SHUN NAGAO | M | - |
INSEAD
| 1 jaar |
Min Hu | M | - |
NCL Technology Ventures Ltd.
![]() NCL Technology Ventures Ltd. Investment ManagersFinance NCL Technology Ventures Ltd. (NCL Technology Ventures) is an venture capital firm founded in 2010 by Jerry Biggs. The firm is headquartered in London, United Kingdom. | 1 jaar |
Francisco Simão | M | 41 |
INSEAD
| 2 jaar |
Nicola de Cesare | M | - |
INSEAD
| 1 jaar |
Adrian Suherman | M | 51 |
INSEAD
| 2 jaar |
Gianpaolo Santorsola | M | - |
INSEAD
| 2 jaar |
Antoine de Peguilhan | M | - |
INSEAD
| 1 jaar |
Aruna Ramsamy | F | - |
INSEAD
| 1 jaar |
Lay Lee Teo | M | 45 |
The University of Manchester
| 4 jaar |
Barry Anderson | M | - |
The University of Manchester
| 4 jaar |
Julia Coelho | F | - |
INSEAD
| 1 jaar |
Koon Liang Ong | M | 45 |
The University of Manchester
| 4 jaar |
Hender Grievink | M | - |
INSEAD
| 1 jaar |
Joao Rodrigues | M | - |
INSEAD
| 2 jaar |
Gavin Adda | M | - |
INSEAD
| 2 jaar |
Matt Mendell | M | - |
INSEAD
| 3 jaar |
Xin Fu | F | 54 |
INSEAD
| 2 jaar |
Victor Carreras-Candi | M | - |
INSEAD
| 1 jaar |
Xiao Jing Yu | F | 47 |
INSEAD
| 2 jaar |
Rina Meileene binti Adam | F | 47 |
The University of Manchester
| 4 jaar |
Martha Heitmann | F | - |
INSEAD
| 1 jaar |
Lodewijk Graauw | M | - |
INSEAD
| 1 jaar |
Eyad Redha Abdulla Faraj | M | - |
INSEAD
| 2 jaar |
Valérie Coscas | F | 49 |
INSEAD
| 2 jaar |
Tarek Kabrit | M | - |
INSEAD
| 1 jaar |
Karoline Rosenberg | F | - |
INSEAD
| 1 jaar |
Wriju Ray | M | - |
INSEAD
| 2 jaar |
Marcello Rodrigues Leone | M | 48 |
INSEAD
| 2 jaar |
Rupert Holdsworth Hunt | M | - |
The University of Manchester
| 4 jaar |
J. Brown | M | 67 |
INSEAD
| 5 jaar |
Ioannis Karyotis | M | 47 |
INSEAD
| 2 jaar |
Nicolas Houzé | M | 49 |
INSEAD
| 1 jaar |
Leandro Fachin Balbinot | M | 54 |
INSEAD
| 2 jaar |
Abby Yu | F | - |
The University of Manchester
| 4 jaar |
Dave Krupinski | M | 57 |
INSEAD
| 2 jaar |
Catherine Carter-Worrall | F | 44 |
The University of Manchester
| 4 jaar |
John Eric F. P. C. Bertrand | M | 46 |
INSEAD
| 2 jaar |
Chee Mun Cheng | M | - |
INSEAD
| 1 jaar |
Fabio Riccelli | M | - |
The University of Manchester
| 3 jaar |
Maher Mohammed Najib Azmi Mikati | M | 44 |
INSEAD
| 1 jaar |
Alexandre Bonnécuelle | M | 45 |
INSEAD
| 1 jaar |
Lucas Evans | M | 44 |
INSEAD
| 1 jaar |
Andreas Bernström | M | 50 |
The University of Manchester
| 3 jaar |
Anton Viktorovich Lopatin | M | 49 |
INSEAD
| 2 jaar |
Oridian Lev | M | - |
The University of Manchester
| 4 jaar |
Danny Brower | M | - |
The University of Manchester
| 3 jaar |
Alona Bar On | F | 46 |
INSEAD
| 2 jaar |
Vivek Verma | M | - |
The University of Manchester
| 3 jaar |
Aizhan Dykanbayeva | F | 46 |
INSEAD
| 2 jaar |
Paul Andrew Cocker | M | 45 |
The University of Manchester
| 3 jaar |
Luis Fontecha Andujar | M | - |
The University of Manchester
| 4 jaar |
Job Heimerikx | M | - |
INSEAD
| 4 jaar |
Rutvik Doshi | M | - |
INSEAD
| 1 jaar |
Darren Edward Wills | M | - |
The University of Manchester
| 3 jaar |
Vinay Ruparelia | M | - |
The University of Manchester
| 3 jaar |
Yinglan Tan | M | - |
INSEAD
| 1 jaar |
Samir Satish Jhaveri | M | - |
INSEAD
| 1 jaar |
Antoine Rouland | M | - |
INSEAD
| 1 jaar |
Harinder Pal Singh Takhar | M | 46 |
INSEAD
| 1 jaar |
Yulia Viktorovna Sklar | F | 53 |
INSEAD
| 1 jaar |
Maxim Ageyev | M | 56 |
INSEAD
| 4 jaar |
Takashi Kokubo | M | 50 |
INSEAD
| 2 jaar |
Sara Redford | F | - |
The University of Manchester
| 22 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigd Koninkrijk | 50 | 50.00% |
Frankrijk | 50 | 50.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Jonathan Synett
- Persoonlijk netwerk